SIS: Southend Imaging Study

Sponsor
Mid and South Essex NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT02736396
Collaborator
Anglia Ruskin University (Other)
37
1
51
0.7

Study Details

Study Description

Brief Summary

The study objective is to correlate global cognition and episodic memory performance to resting state fMRI functional connectivity. This is a non-treatment, prospective, natural history data collection study in a cross-sectional cohort of patients with cognitive impairment.

Condition or Disease Intervention/Treatment Phase
  • Other: fMRI
  • Other: Neuropsychological tests

Detailed Description

At present, Magnetic Resonance Imaging (MRI) is widely used along with other tests to help diagnose dementia, however diagnosis still remains challenging. There is currently a focus on the usefulness of resting state functionalMRI (RS fMRI) as a way of establishing differences in functional connectivity between healthy subjects and those with various neurodegenerative disorders. Although the potential for RS fMRI to be used as a biomarker for neurological diseases looks promising, further research is needed, especially regarding validation of normal values and seed-based functional connectivity. Further research into this area will help to improve the ability to appropriately classify new subjects and ultimately allow use of RS functional connectivity as a biomarker. This is a nontreatment, prospective, natural history data collection that aims to analyse functional connectivity in a cohort of patients with suspected cognitive impairment. Correlation of global cognition and episodic memory performance to resting state fMRI functional connectivity will be evaluated. Patient population will include patients over the age of 18 with cognitive impairment and age and gender matched controls. Eligible patients will have to complete neuropsychological and clinical assessments and complete an fMRI scan prior to enrolment.Study duration is estimated at 4 years.

Study Design

Study Type:
Observational
Actual Enrollment :
37 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Southend Imaging Study
Actual Study Start Date :
Jun 1, 2016
Actual Primary Completion Date :
Nov 1, 2019
Actual Study Completion Date :
Sep 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Healthy Controls

Medical History, Neuropsychological tests, clinical assessments, fMRI

Other: fMRI
Functional MRI scan to be performed

Other: Neuropsychological tests
Cognitive assessments will be performed, including Mini Mental State Examination, Rey Auditory Verbal Learning Test, Stroop, Visual Short Term Memory Assessment.

Cognitive impairment

Medical History, Neuropsychological tests, clinical assessments, fMRI

Other: fMRI
Functional MRI scan to be performed

Other: Neuropsychological tests
Cognitive assessments will be performed, including Mini Mental State Examination, Rey Auditory Verbal Learning Test, Stroop, Visual Short Term Memory Assessment.

Outcome Measures

Primary Outcome Measures

  1. Evaluation of the functional connectivity in the Default Mode Network . [4 years]

    Evaluating the correlation of the Default Mode Network functional connectivity to types of dementia.

Secondary Outcome Measures

  1. Correlation of cognitive performance to functional connectivity. [4 years]

    To evaluate the correlation between individual measures of functional connectivity and global and episodic cognitive performance as measured by neuropsychological tests.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Informed consent

  • Cognitive impairment

  • Age from 18 to 100 years

  • On stable medication for 1 month before the screening visit; on or off cholinesterase inhibitors

  • Fluency in English and adequate premorbid intellectual functioning

Exclusion Criteria:
  • Any contraindication to MRI scanning

  • Clinically significant psychiatric disorder (e.g. depression)

  • Current clinically significant illness that could confound the results of the study

  • History of alcohol or drug dependence or abuse

  • Current use of anticonvulsant or narcotic medications.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Southend Hospital Westcliff on Sea Essex United Kingdom SS0 0RY

Sponsors and Collaborators

  • Mid and South Essex NHS Foundation Trust
  • Anglia Ruskin University

Investigators

  • Principal Investigator: Paula A Harman, BSc, Southend University Hospital NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mid and South Essex NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT02736396
Other Study ID Numbers:
  • P0867
First Posted:
Apr 13, 2016
Last Update Posted:
Dec 22, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 22, 2020